Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 December 2018 | Story Charlene Stanley | Photo Charlene Stanley
Prof Helena Strauss
Prof Helena van Zyl, Director of the UFS Business School, says the accreditation endorses their important role in empowering business leaders.

The Business School of the University of the Free State (UFS) received an International Qualifications Assessment accreditation by the Central and East European Management Development Association (CEEMAN) this week.
 
“This is an endorsement for the level of quality and relevance of the Business School. I’ve been inundated with well-wishes via phone and emails from current and former students. They all realise the tremendous benefits this holds for everyone affiliated with our Business School, as the quality of our qualifications are now recognised globally,” says Prof Helena Van Zyl, Director of the UFS Business School.

“On behalf of the executive management, I would like to congratulate Prof Van Zyl and her team on this fine achievement. The accreditation is a feather in the cap of the university and it is indeed an accomplishment to be proud of,” says Prof Francis Petersen, Rector and Vice-Chancellor of the UFS.
  
CEEMAN is an international management-development association with the aim of accelerating the growth in quality of management development in Central and Eastern Europe. The association has more than 220 members from over 55 countries in Europe, North America, Latin America, Africa, and Asia.

Thorough evaluation process

The accreditation is the culmination of two years of hard work – first to apply by submitting an overview of operations, then drawing up a self-assessment report with appendices of over 1 000 pages. Finally, a peer-review team with panel members from Latvia, Poland, and Mauritius came to the Bloemfontein Campus for an on-site assessment. In two and a half days, the panel conducted detailed, thorough interviews with 85 different people – from staff and students, to industry partners, the dean, and members of the rectorate.
    
Aspects which the panel focused on included the school’s mission and strategic focus, legal status and governance, research output, physical facilities, financial viability, contribution to the local community, use of technology, and even how environmental needs are met.

“It’s been an incredibly intense but very rewarding experience,” says Prof Van Zyl. “The review team was very professional and strategic in their approach and also gave valuable input and advice.” 

Team members were particularly impressed by the overwhelmingly positive experiences recorded by students, as well as the state-of-the-art facilities.

Passionate about people

“We think of ourselves as a ‘Boutique Business School’ ”, explains Prof Van Zyl. “We are focused on quality and are extremely structured and disciplined, which ultimately creates a safety net for students and staff. We’re also small enough to build personal relationships with our students.”

She believes this to be the secret of the Business School’s tremendous success record over the 20 years of its existence.

“We are passionate about people and believe in creating a caring environment for them while they’re here.”  

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept